Direkt zum Inhalt
Merck

Fortfahren mit

C5851

CGP 35348 hydrate

≥97% (NMR), solid

Synonym(e):

(3-Aminopropyl)(diethoxymethyl)phosphinic acid hydrate

Anmelden zur Ansicht der Organisations- und Vertragspreise.

Größe auswählen

Ansicht ändern
Ihnen/SKUVerfügbarkeitPreis
5 mg
Warenkorb auf Verfügbarkeit prüfen
€ 199,00
€ 169,15
25 mg
Warenkorb auf Verfügbarkeit prüfen
€ 606,00

Über diesen Artikel

Empirische Formel (Hill-System):
C8H20NO4P · xH2O
CAS-Nummer:
Molekulargewicht:
225.22 (anhydrous basis)
NACRES:
NA.77
PubChem Substance ID:
UNSPSC Code:
12352200
MDL number:
Assay:
≥97% (NMR)
Form:
solid
Storage condition:
desiccated

€ 169,15

Listenpreis€ 199,00Sparen Sie 15%
Aktion nur im Web

Warenkorb auf Verfügbarkeit prüfen

Sonderanfertigung anfragen
Technischer Dienst
Benötigen Sie Hilfe? Unser Team von erfahrenen Wissenschaftlern ist für Sie da.
Unterstützung erhalten


Quality Segment

assay

≥97% (NMR)

form

solid

storage condition

desiccated

color

white

solubility

H2O: >20 mg/mL

originator

Novartis

storage temp.

−20°C

SMILES string

O.CCOC(OCC)P(O)(=O)CCCN

InChI

1S/C8H20NO4P.H2O/c1-3-12-8(13-4-2)14(10,11)7-5-6-9;/h8H,3-7,9H2,1-2H3,(H,10,11);1H2

InChI key

SRBHGEXMDCJOMS-UHFFFAOYSA-N

Application

CGP 35348 hydrate has been used as a γ-aminobutyric acid-B (GABAB) receptor inhibitor:
  • to study its effects on intrinsic optical signal (IOS) in rat hippocampus
  • alone or in combination with sodium salicylate to study its effects on auditory responses in the rat′s dorsal cortex of rat
  • to study its effects on hepatocellular carcinoma cells (HCC)

Biochem/physiol Actions

CGP 35348 is a γ-aminobutyric acid-B (GABAB) receptor antagonist. It has a higher affinity towards post-versus presynaptic receptors that can penetrate the blood-brain barrier.

Features and Benefits

This compound is a featured product for Neuroscience research. Click here to discover more featured Neuroscience products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm.
This compound is featured on the GABAB Receptors page of the Handbook of Receptor Classification and Signal Transduction. To browse other handbook pages, click here.
This compound was developed by Novartis. To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here.

Disclaimer

Product is hygroscopic

Ähnliche Artikel vergleichen

Vollständigen Vergleich anzeigen

Unterschiede anzeigen

1 of 1

Dieser Artikel
SML0475SML0593T200
description

≥97% (NMR), solid

description

≥97% (NMR)

description

≥98% (HPLC)

description

≥97% (HPLC), solid

form

solid

form

powder

form

powder

form

solid

assay

≥97% (NMR)

assay

≥97% (NMR)

assay

≥98% (HPLC)

assay

≥97% (HPLC)

Quality Level

100

Quality Level

100

Quality Level

100

Quality Level

100

storage temp.

−20°C

storage temp.

room temp

storage temp.

2-8°C

storage temp.

-

solubility

H2O: >20 mg/mL

solubility

H2O: 10 mg/mL (clear solution, warmed)

solubility

H2O: 1 mg/mL, clear (warmed)

solubility

H2O: 16 mg/mL, DMSO: insoluble

storage condition

desiccated

storage condition

desiccated

storage condition

desiccated

storage condition

-


Lagerklasse

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Dokumente section.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen



Questions

Reviews

No rating value

Active Filters